COVID-19 pandemic should prompt rethinking of health care for Medicare beneficiaries: OHSU co-author.

OHSU-led research scours 77 studies worldwide about length of time COVID-positive people may be infectious.

Eric Gouaux earns one of the highest honors in the fields of health, medicine.

Jacobs writes about new study into treatment for appendicitis in New England Journal of Medicine.

Oregon National Primate Research Center also will use grant to study impact of alcohol on COVID-19.

Sen. Wyden consults OHSU telehealth, psychiatric experts in sponsoring legislation.

Oregon National Primate Research Center has strong track record in genetic analysis, data sharing.

OHSU-led study is first to assess association between the new model and changes in racial, ethnic disparities in hip, joint replacements.

Patients who miss visits are at a higher risk of negative health outcomes; no-shows increase health care system costs.

OHSU expert warns that cloth masks are insufficient for wildfire smoke, may give false sense of security.

Understanding these cells (astrocytes) is key to understanding autism spectrum disorder, schizophrenia.

Commission endorses more research, lays out pathway to clinical applications for gene editing.

OHSU study finds three-quarters of hospitalized people with opioid use disorder report using more than one substance.

El programa comunitario de Hillsboro Medical Center tiene una larga trayectoria, y se enfoca en prevenir la propagación de COVID-19 entre los trabajadores de viñedos y vinicultores.

Nationwide trial to test effectiveness of convalescent plasma to treat people with mild symptoms of COVID-19.

Low-barrier mobile testing sites provide community service amid COVID-19 pandemic.

Six of the hospital’s adult specialties are ranked among the best in the nation.

OHSU study uses programmable RNA editing to repair gene that contributes to Rett syndrome.

Longtime Hillsboro Medical Center community outreach program pivots to preventing the spread of COVID-19 among vineyard, winery workers.

OHSU establishes remote emergency response critical care network as part of Army-funded project.

OHSU-led research finds alternative payment model reduces imaging by 42%.

Five-year NIH award will enable study of herbs that could help maintain brain health, function in aging.

OHSU survey finds growing acceptance of complementary and alternative medicine.

Author says even a small effect can have a big impact on reducing exponential spread of novel coronavirus.

OHSU research targets disease afflicting millions in developing world.

Award to OHSU is first federal funding for new field of medicine.

OHSU algorithm could be useful in maintaining safe levels of glucose.

Reliable blood tests to detect past infection will be crucial in stopping COVID-19 pandemic.

Forgoing a trip to the emergency room can be dangerous.

Magnetic resonance imaging in rhesus macaques detects effects of binge drinking early in pregnancy.

OHSU researchers examine trove of data from VA.

World Health Organization-sponsored review by OHSU scientists finds education, training are key.

A new tool monitors COVID diagnoses and 90% of hospital beds around state.

OHSU team designs low-cost ventilators using 3D-printing technology.

Line offers advice for patients without primary care, clinicians throughout Oregon.

Leading U.S. universities join together to address public health crisis.

Global pandemic instigates exponential expansion of OHSU telemedicine program.

Findings in mice reveal possibilities for fetal drug therapy to treat deafness.

OHSU research will focus on machine-learning software.

Review informs new recommendation for universal screening.

OHSU, Legacy distribute awards to boost trauma care beyond Portland.

Patients say life post-surgery is ‘better than my best expectations.’

Program by the American Society of Surgeons aims to evaluate hospitals’ ability to provide the highest standards of surgical care.

OHSU, OSU researchers examine commonly prescribed medication for multiple sclerosis.

​Modern tools to improve interpersonal communication may be having the opposite effect.

OHSU will help compare two treatment protocols to determine the preferred standard.

Mouse model insight could focus future hearing loss reversal research on early development.

OHSU joins OSU, PSU, UO, OIT on new agreements to share research facilities.

Opioid use disorder medications proven to cut the death rate from opioid addiction by more than 50%.

OHSU study enrolling participants now in the Portland area.

Study provides insight about drug industry price-setting.

Online resource helps weed out bias, conflicts of interest, unproven therapies for anyone affected by opioid use disorder.

​OHSU joins OSU, PSU, UO, OIT on new intellectual property agreement.

OHSU Health is the first system in Oregon to implement drug pricing comparison tool.

Portland athlete sets sights on 2020 Paralympic Games in Tokyo.

Esketamine may not be as effective as physicians and patients have been led to believe.

New compound, tested in mice and human cells, corrects abnormalities that cause the disease.

OHSU neurotoxicologists highlight ‘significant global health issue’ for undernourished people around the world.

Patients whose heartburn persists despite medication may benefit from surgery, study finds.

Findings may provide insight about development of neurodegenerative conditions like Parkinson’s disease.

Language mapping enables OHSU surgeons to remove tumors while preserving cognitive function.

OHSU lands NIH award to test new ways to help people caring for family members with Alzheimer’s.

NIH names OHSU among 20 teams focused on improving research and treatment of rare diseases.

Junior biology major works to ‘solve my own problem and also help others.’

After enduring two life-threatening medical emergencies in one day, Earl Heberlein could have died, but is now back to normal thanks to his coworkers’ quick reaction, and the seamless care between Tuality Healthcare and OHSU.

Award will upgrade national center for electron-microscopy.

OHSU-led research could lead to clinical trials in people with multiple sclerosis or other neurodegenerative conditions.

OHSU’s innovative in-hospital addiction program proves successful in engaging people in treatment.

Technique could help diagnose, rectify a genetic defect with gene-editing tools such as CRISPR.

Study reveals the crucial role of alpha-synuclein protein in DNA repair.

Scientists at the OHSU Vollum Institute develop animal model for disease chronicled in a novel and film.

OHSU research reveals prolific ability of Schwann cells to generate myelin.

OHSU research discovers a gene in mice that’s activated by brief periods of exercise.

Results highlight need for better education to improve health care for sexual and gender minorities.

OHSU’s Shoukhrat Mitalipov and his son publish a perspective in Nature Medicine.

Research Week 2019: OHSU scientist Andrew Adey focuses on new methods to efficiently profile single cells.

Research Week 2019: Neurologist probes link between inadequate sleep, autism, other neurological disorders.

Survey suggests better training needed for general internal medicine residents.

​Optical fibers and ultra-high-field MRIs enable scientists to view brain connections.

Neurosurgeon publishes commentary on the preponderance of left-handed U.S. presidents.

Research led by OHSU scientists opens avenues for creating medications to treat addiction.

OHSU researchers collaborate on potential ‘game-changer’ for people with multiple sclerosis.

Native structure of a receptor may lead to finding the mechanism behind conditions like Alzheimer’s disease.

OHSU study is first to pinpoint a decrease in brain volume, potentially limiting lifetime learning ability.

As the most common infection among sick patients in intensive care units, OHSU will begin its clinical trial to test if a specialized breathing tube can reduce the risk of pneumonia in emergency intubation situations.

OHSU research tests video chat as a way to prevent cognitive decline.

Symptoms assessed via live audio-video connection with OHSU providers.

OHSU study finds opioids are easy to get, but medication-assisted addiction therapy is not.

OHSU expert co-authors commentary in The Lancet.

Identification of the gene provides hope, as there are currently only a handful of FDA-approved drugs for alcoholism.

Medicare beneficiaries now pay thousands of dollars annually.

OHSU School of Medicine’s pain intersession stands out among medical schools nationwide.

OHSU’s Partnership Project and HIV clinic focus on treatment and prevention.

OHSU Thyroid and Parathyroid Center follows a new post-surgery prescribing initiative.

A study measures the effectiveness of online communication tools in combatting depression among socially isolated seniors.

Pain experts downplay use of opioids for back pain treatment.

The embryologist was recognized for his work utilizing gene-editing tools to prevent inherited disease.

A first-of-its kind study finds face-to-face contact reduces the risk of mental health problems among military veterans.

A project led by the Oregon National Primate Research Center at OHSU has attracted interest from researchers worldwide.

Discovery could lead to new treatments for addiction.

OHSU Brain Institute partners with Oregon Symphony to host "Music and the Mind" event.

The breakthrough could lead to ‘new and better blood pressure medications.’

OHSU expert co-authors viewpoint: ‘Time’s up for medicine? Only time will tell.’

A new study shows that patients with asthma have denser airway nerves, leading to more severe symptoms.

NIH-funded trial offers hope for disease with limited treatment options.

New findings reveal a substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed.

Bryan Black, first patient in Oregon to undergo brain surgery with an assist from a robot.

Research published in Nature confirms discovery of DNA repair mechanism.

OHSU discovery could accelerate development of new gene therapies for Batten disease.

National Academies publishes proceedings from workshop discussions, presentations.

OHSU physician leads clinical trial for new treatment of PKU.

Researchers in the OHSU Balance Disorders Laboratory develop new insights about detecting, treating problems after concussions.

OHSU included in an expanded clinical trial assessing the effectiveness of immunotherapy to treat or slow Parkinson's disease.

OHSU surgically implants device to treat sleep apnea.

Besides the physical limitation, experts say that children missing a limb can experience lasting psycho-social effects that can shape the course of their lives.

The clinical trial will recruit 20 children, fitted with custom-designed arms, and gauge the functionality and effect on their quality of life.

$128 million NIH grant provides state-of-the-art electron microscopy technology, training to scientists nationwide.

OHSU’s Eric Gouaux has already amassed prolific record of discoveries about how the brain works.

Working with patients directly informs this Parkinson’s research.

Physician uses basic science research to improve treatment of pituitary conditions .

Providers who participated an initiative to address the opioid epidemic, say the program reframed addiction as a treatable chronic disease.

Local medical teams consulted with experts through the OHSU Telemedicine Network, quickly administering brain-saving treatment.

Findings have significant implications for opioid conversations between patients and their providers.

Discovery allows scientists to index thousands of cells simultaneously, a 40-fold increase from the current method.

Study authors say education, staying active should be first line of treatment.

Roseburg-area woman ready to get back on the saddle after extensive spinal surgery at OHSU.

OHSU researchers reveal an ion channel that could be a target for medications.

Authors stress that because hearing cells are not regenerated, it is critical to understand and protect this important sensation.

OHSU neuroscientist Anna Wang Roe is working on the cutting edge of optical and MRI technology.

As Valentine’s Day approaches, generations of poets and songwriters are unanimous in their verdict: Love is all about heart. OHSU neuroscientist Larry Sherman, Ph.D. says they’re all wrong.

The study focuses on how SSRIs interact with the protein that transports serotonin in the brain.

Efforts to reverse the nation’s opioid epidemic remain beset by the stigma associated with drug use, a group of OHSU researchers write in a year-end review.

A $5 million grant will enable neuroscientists at the OHSU Vollum Institute to map circuits in the amygdala, the deep brain structure that contains circuitry critical for emotion.

OHSU internist says treatment of substance use disorder often falls to primary care physicians, who lack resources and support.

Researchers say more data is needed to understand the best way to administer the drug for optimum effectiveness.

A unique OHSU program strives to forestall memory loss through walking and reminiscing in north and northeast Portland.

Spinal surgery clears way for life-saving liver transplant for OHSU patient.

A panel of experts highlight the need to reduce stigma and enhance treatment for opioid addiction.

Research identified a specific network in the brain closely tied to risk assessment.

OHSU study indicates clinical outcomes for deep brain stimulation while patients are asleep are on par or better than surgery while awake.

Recognizing the signs of a stroke early can make the difference between life and death for stroke victims.

A new study reveals that directly connecting with patients by phone makes a major difference in reducing the number of no-shows.

A brain surgery simulator developed at OHSU allows doctors to gain experience without risking the lives of patients.

OHSU emergency department participating in a nationwide clinical trial.

The Oregon Clinical & Translational Research Institute at OHSU has received a $37 million boost from the federal government to help accelerate the translation of research into clinical use, medical practice and health policy.

Scientists have uncovered two related cytokines and associated genetic markers that may explain why some people develop progressive multiple sclerosis, or MS.

Researchers report that Medicare spent over $1 billion in a five-year period for a drug that has not proved more effective than a cheaper alternative.

Executive leadership involvement and data-driven management are among four strategies to help reduce emergency room crowding, study says.

Study indicates that a common class of antidepressants may worsen tinnitus.

OHSU leads team to prevent cardiomyopathy through gene correction.

New research shows eating a high-fat diet when pregnant could alter the development of the baby's brain and endocrine system development.

Scientists in the Vollum Institute at OHSU have identified an enzyme that plays a crucial role in the degeneration of axons, the threadlike portions of a nerve cell that transmit signals within the nervous system.

Claudio Mello, Ph.D., a professor of behavioral neuroscience in the OHSU School of Medicine who studies zebra finches shares his thoughts about the role of birds in understanding human biology and his growing appreciation for the natural world.

Using a 3D printer, Albert Chi, M.D. constructed a pair of prosthetic hands for a 6-year-old Astoria boy.

An OHSU pilot study suggests the over-the-counter antioxidant lipoic acid holds promise in improving the lives of patients with secondary progressive multiple sclerosis.

A systematic review of basic and clinical science research has revealed no definitive standard for detecting military veterans at risk of suicidal behavior, nor is there a clear standard of treatment to prevent suicide among U.S. veterans.

Chris Ramsey, a physical therapist who lives in Beaverton, Oregon, is currently training for the Race Across the West, a 930-mile bike race from southern California to Colorado that begins June 13. Notably, he is believed to be the first person with MS to attempt the race solo.

Kevin Wright, Ph.D. is an assistant professor running his own laboratory in OHSU’s Vollum Institute, where he applies his natural curiosity toward solving one of the most formidable puzzles in science and medicine: how the nervous system works.

Gail Mandel, Ph.D., is helping to develop a gene therapy technique to repair a mutation on the X chromosome which causes the neurological disease Rett syndrome.

Tianyi Mao, Ph.D., maps what she refers to as the “connectome,” how different parts of the brain connect together to perform different tasks.

A new study makes a business case for establishing an in-hospital intervention program for patients affected by substance use disorder.

Elizabeth Whispell maintains an active lifestyle, so she didn’t give much thought to what seemed to be subtle changes in her appearance. It wasn’t until later that she learned she actually had a rare pituitary disorder – a condition serious enough that it ultimately required brain surgery by specialists at OHSU in Portland.

OHSU doctors and scientists working to address the opioid epidemic which has claimed thousands of lives and resulted in a doubling of the number of people who reported heroin addiction in a single decade, from 2003 to 2013.

Research published online in the journal Endocrinology found that a small synthetic molecule initially developed to lower cholesterol may slow or stop the devastating progression of the neurodegenerative disease adrenoleukodystrophy, or ALD. The study was conducted in a mouse model, but planning is under way for a human clinical trial.

Stroke medication currently available must be given within three hours to have the maximum benefit, but many patients do not make it to the hospital in time to receive it. A newly developed potential treatment involving the use of stem cells to promote brain recovery may greatly extend this window.

A unique OHSU psychiatric program supports immigrants and refugees, serving approximately 1,100 people in the Portland area, including 200 survivors of torture from countries including Iraq, Iran, Somalia, Ethiopia, Bosnia and Syria.

A powerful class of antibiotics provides life-saving relief for people with cystic fibrosis; however, a new study for the first time reveals the levels at which high cumulative dosages over time significantly increases the risk of permanent hearing loss in these patients.

U.S. taxpayers spent more than $650 million in 2013 and 2014 on one medication with questionable usefulness prescribed by less than 1 percent of clinicians, according to new research by scientists with OHSU and the OHSU/Oregon State University School of Pharmacy in Portland.

OHSU scientists have uncovered a method for quickly and efficiently mapping the genome of single cells within the body. Their findings, published Jan. 30 in the journal Nature Methods, clears the way for a significant advance in precision medicine, including cancer and many other disease areas.

OHSU research suggests an avenue for developing treatments for chronic pain that harness the medicinal properties of cannabis while minimizing the threat of addiction.

A local woman can now to look her husband and two grown children in the eye after undergoing a successful surgery to correct a rare and debilitating spinal condition known as dropped head syndrome.

A new scientific discovery may provide a future avenue for treatment and prevention of Alzheimer’s disease.

A new discovery may unlock the answer to a vexing scientific question: How to conduct mitochondrial replacement therapy, a new gene-therapy technique, in such a way that safely prevents the transmission of harmful mitochondrial gene mutations from mothers to their children.

When the possibility of death is the only alternative, most people will opt for the most aggressive cancer treatments possible. The problem is, a new study by researchers at OHSU suggests that a robust combination of therapies that are effective in targeting the cancer can lead to harmful cognitive effects in the brain if the patient survives.

Long-term exposure to cosmic radiation could alter the brain and change behavior in astronauts bound for Mars, according to new research led by scientists at OHSU in Portland, Oregon.

Scientists for the first time have documented a newly understood pathway for transmitting signals within the brain, according research published online Nov. 9 in the journal Nature.

Families struggling with infertility or a genetic predisposition for debilitating mitochondrial diseases may someday benefit from a new breakthrough led by scientists at OHSU and the Salk Institute for Biological Studies.

New four-year demo project expands in-home tracking to households in Portland, Chicago and Miami.

In a new study published online today in The Journal of Neuroscience, researchers found that chronic administration of estradiol boosts cognitive performance in aged female rhesus monkeys.

A breakthrough study published online this week in the journal Nucleic Acids Research suggests that it may be possible to treat genetic disease detected in the womb by safely and efficiently delivering gene-altering therapies through a kind of reverse amniocentesis.

A panel of leading experts today issued the 4th Edition of the Guidelines for the Management of Severe Traumatic Brain Injury. The updated guidelines provide recommendations for 18 monitoring and treatment topics for patients with severe traumatic brain injuries, or TBI, including surgical procedures, the use of monitors that measure intracranial pressure, preventing and treating brain swelling, and nutrition.

Opioid abuse and addiction is a tremendous national problem, claiming thousands of lives and doubling the number of people who reported heroin addiction in a single decade (2003 to 2013).

New research reveals for the first time the atomic structures of a key molecular receptor in the brain, which opens the door for developing medications that could block activation of these receptors to address a variety of conditions, ranging from pain to high blood pressure to early formation of blood clots.

A first-of-its-kind controlled clinical trial found that a low-fat, plant-based diet significantly improved the health of people with multiple sclerosis by reducing both fatigue and weight. Those improvements go hand-in-hand with fighting some of the most debilitating effects of MS.